Bioequivalency Study of Levetiracetam 750 mg Tablets Under Fasting Conditions

Completed · Not applicable

Conditions studied: Seizures

In brief

The objective of this study was to prove the bioequivalence of Levetiracetam 750 mg Tablets under fasted conditions

Key facts

Study ID

NCT00826865

Run by

Roxane Laboratories

People needed

27

Starts

2005-08-01

Expected to finish

2005-08-01

Last updated by the study team

2018-01-23

Who can join

Age: 18 and older, up to 45. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• No clinically significant abnormal findings on the physical examination, medical history, or clinical laboratory results during screening

You may not qualify if…

• Positive test for HIV, Hepatitis B, or Hepatitis C. Treatment with known enzyme altering drugs. History of allergic or adverse response to Levetiracetam or any comparable or similar product.

Where it is running

• MDS Pharma Services — Phoenix, Arizona, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.